| Product Code: ETC13261148 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Infectious Disease Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Infectious Disease Diagnostics Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Infectious Disease Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 North America Infectious Disease Diagnostics Market - Industry Life Cycle |
3.4 North America Infectious Disease Diagnostics Market - Porter's Five Forces |
3.5 North America Infectious Disease Diagnostics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Infectious Disease Diagnostics Market Revenues & Volume Share, By Product & Service, 2021 & 2031F |
3.7 North America Infectious Disease Diagnostics Market Revenues & Volume Share, By Type of Testing, 2021 & 2031F |
3.8 North America Infectious Disease Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 North America Infectious Disease Diagnostics Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.10 North America Infectious Disease Diagnostics Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.11 North America Infectious Disease Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Infectious Disease Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Infectious Disease Diagnostics Market Trends |
6 North America Infectious Disease Diagnostics Market, 2021 - 2031 |
6.1 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Reagents, Kits, and Consumables, 2021 - 2031 |
6.1.3 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.1.4 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Software & Services, 2021 - 2031 |
6.2 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Type of Testing, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Laboratory Testing, 2021 - 2031 |
6.2.3 North America Infectious Disease Diagnostics Market, Revenues & Volume, By PoC Testing, 2021 - 2031 |
6.3 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Immunodiagnostics, 2021 - 2031 |
6.3.3 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Polymerase Chain Reaction, 2021 - 2031 |
6.3.4 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Clinical Microbiology, 2021 - 2031 |
6.3.5 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology, 2021 - 2031 |
6.3.6 North America Infectious Disease Diagnostics Market, Revenues & Volume, By DNA Sequencing & Next-generation Sequencing, 2021 - 2031 |
6.3.7 North America Infectious Disease Diagnostics Market, Revenues & Volume, By DNA Microarray, 2021 - 2031 |
6.3.8 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Other Technologies, 2021 - 2031 |
6.4 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Hepatitis, 2021 - 2031 |
6.4.3 North America Infectious Disease Diagnostics Market, Revenues & Volume, By HIV, 2021 - 2031 |
6.4.4 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Hospital-acquired Infections, 2021 - 2031 |
6.4.5 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Mosquito-borne Diseases, 2021 - 2031 |
6.4.6 North America Infectious Disease Diagnostics Market, Revenues & Volume, By HPV, 2021 - 2031 |
6.4.7 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Chlamydia trachomatis, 2021 - 2031 |
6.4.8 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Other Infectious Diseases, 2021 - 2031 |
6.5 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Blood, Serum, and Plasma, 2021 - 2031 |
6.5.3 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Urine, 2021 - 2031 |
6.5.4 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Other Sample Types, 2021 - 2031 |
6.6 North America Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031 |
6.6.3 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Hospitals & Clinics, 2021 - 2031 |
6.6.4 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Academic Research Institutes, 2021 - 2031 |
6.6.5 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Other End Users, 2021 - 2031 |
7 North America Infectious Disease Diagnostics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
7.2.1 United States (US) Infectious Disease Diagnostics Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
7.2.2 Canada Infectious Disease Diagnostics Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
7.2.3 Rest of North America Infectious Disease Diagnostics Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
7.3 North America Infectious Disease Diagnostics Market Revenues & Volume Share, By Type of Testing, 2021 & 2031F |
7.3.1 United States (US) Infectious Disease Diagnostics Market, Revenues & Volume, By Type of Testing, 2021 - 2031 |
7.3.2 Canada Infectious Disease Diagnostics Market, Revenues & Volume, By Type of Testing, 2021 - 2031 |
7.3.3 Rest of North America Infectious Disease Diagnostics Market, Revenues & Volume, By Type of Testing, 2021 - 2031 |
7.4 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.1 United States (US) Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.2 Canada Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.3 Rest of North America Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.5.1 United States (US) Infectious Disease Diagnostics Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.5.2 Canada Infectious Disease Diagnostics Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.5.3 Rest of North America Infectious Disease Diagnostics Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.6 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.6.1 United States (US) Infectious Disease Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.6.2 Canada Infectious Disease Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.6.3 Rest of North America Infectious Disease Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.7 North America Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7.1 United States (US) Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7.2 Canada Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7.3 Rest of North America Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Infectious Disease Diagnostics Market Key Performance Indicators |
9 North America Infectious Disease Diagnostics Market - Export/Import By Countries Assessment |
10 North America Infectious Disease Diagnostics Market - Opportunity Assessment |
10.1 North America Infectious Disease Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Infectious Disease Diagnostics Market Opportunity Assessment, By Product & Service, 2021 & 2031F |
10.3 North America Infectious Disease Diagnostics Market Opportunity Assessment, By Type of Testing, 2021 & 2031F |
10.4 North America Infectious Disease Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.5 North America Infectious Disease Diagnostics Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
10.6 North America Infectious Disease Diagnostics Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
10.7 North America Infectious Disease Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Infectious Disease Diagnostics Market - Competitive Landscape |
11.1 North America Infectious Disease Diagnostics Market Revenue Share, By Companies, 2022 |
11.2 North America Infectious Disease Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here